| Condition | Key Finding | Association | Board Exam Tip |
| Malignant Hyperthermia ({MH}) | Profound rigidity, hyperthermia | Succinylcholine, Halothane; Ryanodine receptor mutation | Always think of {Dantrolene} as the antidote. |
| Primary Adrenal Insufficiency ({PAI}) | Hyponatremia, Hyperkalemia, Metabolic Acidosis (Type 4 RTA) | Waterhouse-Friderichsen Syndrome; Aldosterone deficiency | The key is aldosterone loss, leading to {K}^+ retention and {Na}^+ wasting. |
| Phenylketonuria ({PKU}) | High phenylalanine levels in blood/urine | Deficiency of Phenylalanine hydroxylase (PAH) | Dietary restriction of phenylalanine is the primary treatment. |
| Carcinoid Syndrome | Diarrhea, Flushing, Right-sided heart lesions | Serotonin excess; {MEN}1 syndrome | Remember the right side: Tricuspid regurgitation and Pulmonary stenosis ({TIPS}). |
| Topic | Key Point | Context | Exam Relevance |
| Malignant Hyperthermia | Triggered by volatile anesthetics/succinylcholine. Treat with Dantrolene. | Muscle rigidity, hypermetabolism during anesthesia. | High-yield pharmacology; know the specific receptor target (ryanodine). |
| Primary Adrenal Insufficiency | {Aldosterone} deficiency causes {K}^+ retention and {Na}^+ wasting. | Waterhouse-Friderichsen Syndrome following meningitis. | Distinguish from secondary AI: Primary AI has high {ACTH}, low 11-deoxycortisol, hyperkalemia. |
| Dopamine Pathway | L-Dopa must be given with Carbidopa to prevent peripheral metabolism. | Parkinson's disease management. | Test the understanding of peripheral vs. CNS enzyme activity ({AADC}). |
| Cholera Diarrhea | Secretory diarrhea due to toxin activating adenyl cyclase -> increased cAMP/{Cl}^- secretion via CFTR. | Developing country, contaminated water source. | Treatment is Oral Rehydration Therapy (SGLT1 transporter). |
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A patient undergoing surgery receives succinylcholine and develops profound muscle rigidity and hyperthermia. | Malignant Hyperthermia ({MH}) | Succinylcholine is a classic trigger, and the presentation (rigidity/hyperthermia) points to {MH}. Treatment requires Dantrolene. |
| A male patient presents with tall stature, infertility, gynecomastia, and micro-penis. | Klinefelter Syndrome (47,XXY) | This constellation of findings is pathognomonic for the karyotype 47,XXY. The relative estrogen excess causes gynecomastia. |
| A child has a calcified mass in the suprasellar region with visual deficits and macrocephaly. | Craniopharyngioma | These are common features associated with pituitary/hypothalamic axis dysfunction and developmental issues in this location. |
| A patient develops severe diarrhea, hypochloremia, and hypokalemia, and has a history of {MEN}1. | {VI Poma} (Watery Diarrhea Syndrome) | The triad (diarrhea, low Cl-, low K+) combined with the association to {MEN}1 strongly suggests {VI Poma}. |
| A patient presents with diarrhea after consuming contaminated water from a developing country. | Cholera | Classic presentation of secretory diarrhea caused by cholera toxin activating adenyl cyclase and increasing cAMP/{Cl}^- secretion via CFTR. |
| A child is born with profound respiratory distress due to herniation of abdominal contents into the chest cavity. | Diaphragmatic Hernia | This defect arises from failure of closure of the pleuroperitoneal membrane during embryonic development. |
| Key Features | Distinguishing Findings | Next Step |
| Secretory Diarrhea (e.g., Cholera, {VI Poma}) | High stool osmolality; Low fecal {pH} (often); Toxin-mediated ion secretion ( cAMP/cGMP). | Treat with fluid replacement and specific antidotes if known (e.g., antibiotics for E. coli toxin). |
| Osmotic Diarrhea (e.g., Lactose intolerance, Acarbose) | Low stool osmolality; Stool contains unabsorbed solutes; Symptoms related to dietary intake. | Dietary modification or enzyme replacement therapy (e.g., lactase drops). |
| Key Features | Distinguishing Findings | Next Step |
| Phenylketonuria ({PKU}) | High phenylalanine levels; Neurological damage if untreated. | Strict, lifelong low-phenylalanine diet. |
| BH4 Deficiency (Secondary {PKU}) | Elevated PAH activity initially; Low cofactor (BH_4) levels. | Supplementation with BH_4 or its precursors. |
| Condition | Association | Mechanism | Clinical Significance |
| Malignant Hyperthermia | Succinylcholine/Halothane exposure | Mutation in the ryanodine receptor (ryanodine) | Requires immediate administration of Dantrolene. |
| Primary Adrenal Insufficiency | Aldosterone deficiency | Impaired {Na}^+ reabsorption at collecting duct; loss of mineralocorticoid effect. | Leads to hyperkalemia and Type 4 RTA. |
| Carcinoid Syndrome | Serotonin excess (5-HT) | Tumor release of vasoactive gut hormones ({VIP}, serotonin). | Causes flushing, diarrhea, and right-sided cardiac valvulitis. |
| Celiac Disease | Autoimmune enteropathy | Immune attack on the brush border; leads to malabsorption. | Associated with low IgA and increased risk of Enteric {T}-cell Lymphoma ({EATL}). |
| Term | Definition | Context | Example |
| Dantrolene | Calcium channel blocker/ryanodine receptor antagonist. | Treatment for Malignant Hyperthermia. | Used during surgery when {MH} is suspected. |
| {VI Poma} | Tumor secreting Vasoactive Intestinal Peptide ({VIP}). | {MEN}1 syndrome; causes secretory diarrhea. | Leads to watery diarrhea, hypochloremia, and hypokalemia. |
| SGLT1 Transporter | Sodium-glucose linked transporter found in the brush border. | Mechanism of glucose reabsorption in the small intestine. | The target for {Na}^+-dependent glucose co-transport; crucial for {ORT}. |
| {AADC} (Aromatic L-amino acid decarboxylase) | Enzyme that converts DOPA to dopamine. | Peripheral metabolism of L-Dopa in Parkinson's disease. | Inhibiting this enzyme with Carbidopa prevents peripheral breakdown. |
| Topic | Study Approach | Priority | Resources |
| Endocrine Emergencies | Focus on the deficiency (aldosterone/cortisol) and its specific electrolyte derangements ({K}^+, {Na}^+). | High. Must know primary vs secondary AI differences. | Review board tables for RTA types and adrenal crisis labs. |
| GI Diarrhea | Create a flow chart: Toxin -> Mechanism (cAMP/cGMP) -> Secretory; Unabsorbed solute -> Osmotic. | High. Focus on the cause of the secretion or osmolality imbalance. | Review specific toxins (E. coli, Cholera) and their mechanisms. |
| Amino Acid Metabolism | Trace the pathway: Phenylalanine -> Tyrosine -> DOPA -> Dopamine, noting all rate-limiting enzymes and inhibitors. | Medium-High. Test integration of biochemistry with pharmacology (Parkinson's). | Use flowcharts to map enzyme deficiencies ({PAH}, BH_4). |
🚫Mistake 3: Assuming all diarrhea is secretory. Always differentiate between osmotic (unabsorbed solutes), secretory (active ion secretion), and malabsorptive (structural damage) causes.
⚠️Trap 1: The \text{PKU} Cofactor Trap: If the deficiency is in the enzyme that regenerates the cofactor (\text{BH}_4 reductase), it results in a secondary \text{PKU}, not a primary PAH deficiency.